Oragenics Statistics Share Statistics Oragenics has 715.84K
shares outstanding. The number of shares has increased by 1.01%
in one year.
Shares Outstanding 715.84K Shares Change (YoY) 1.01% Shares Change (QoQ) 1.01% Owned by Institutions (%) 1.5% Shares Floating 688.32K Failed to Deliver (FTD) Shares 10,055 FTD / Avg. Volume 1.53%
Short Selling Information The latest short interest is 68.03K, so 8.27% of the outstanding
shares have been sold short.
Short Interest 68.03K Short % of Shares Out 8.27% Short % of Float 8.45% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -6.94 and the forward
PE ratio is -1.72.
Oragenics's PEG ratio is
0.08.
PE Ratio -6.94 Forward PE -1.72 PS Ratio 0 Forward PS n/a PB Ratio -346.28 P/FCF Ratio -8.53 PEG Ratio 0.08
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Oragenics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.87,
with a Debt / Equity ratio of -1.55.
Current Ratio 0.87 Quick Ratio 0.87 Debt / Equity -1.55 Debt / EBITDA -0.03 Debt / FCF -0.04 Interest Coverage -354
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-3.52M Employee Count 3 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -98.11% in the
last 52 weeks. The beta is 0.65, so Oragenics's
price volatility has been higher than the market average.
Beta 0.65 52-Week Price Change -98.11% 50-Day Moving Average 2.56 200-Day Moving Average 6.87 Relative Strength Index (RSI) 27.59 Average Volume (20 Days) 656,971
Income Statement
Revenue n/a Gross Profit n/a Operating Income -10.56M Net Income -10.57M EBITDA -10.56M EBIT -10.6M Earnings Per Share (EPS) -1.6
Full Income Statement Balance Sheet The company has 864.84K in cash and 328.53K in
debt, giving a net cash position of 536.31K.
Cash & Cash Equivalents 864.84K Total Debt 328.53K Net Cash 536.31K Retained Earnings -216.79M Total Assets 3.87M Working Capital 137.69K
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -8.6M
and capital expenditures 0, giving a free cash flow of -8.6M.
Operating Cash Flow -8.6M Capital Expenditures n/a Free Cash Flow -8.6M FCF Per Share -1.3
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields OGEN does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for OGEN.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 3, 2025. It was a
backward
split with a ratio of 1:30.
Last Split Date Jun 3, 2025 Split Type backward Split Ratio 1:30
Scores Altman Z-Score -88.6 Piotroski F-Score 3
